{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:52Z","timestamp":1781654452990,"version":"3.54.5"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To implement an in-house developed position monitoring software, SeedTracker, for conventional fractionation prostate radiotherapy, and study the effect on dosimetric impact and intrafraction motion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Thirty definitive prostate radiotherapy patients with implanted fiducial markers were included in the study. All patients were treated with VMAT technique and plans were generated using the Pinnacle planning system using the 6MV beam model for Elekta linear accelerator. The target dose of 60 Gy in 20 fractions was prescribed for 29 of 30 patients, and one patient was treated with the target dose of 78 Gy in 39 fractions. The SeedTracker position monitoring system, which uses the x-ray images acquired during treatment delivery in the Elekta linear accelerator and associated XVI system, was used for online prostate position monitoring. The position tolerance for online verification was progressively reduced from 5\u00a0mm, 4\u00a0mm, and to 3\u00a0mm in 10 patient cohorts to effectively manage the treatment interruptions resulting from intrafraction motion in routine clinical practice. The delivered dose to target volumes and organs at risk in each of the treatment fractions was assessed by incorporating the observed target positions into the original treatment plan.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 27 of 30 patients, at least one gating event was observed, with a total of 177 occurrences of position deviation detected in 146 of 619 treatment fractions. In 5\u00a0mm, 4\u00a0mm, and 3\u00a0mm position tolerance cohorts, the position deviations were observed in 13%, 24%, and 33% of treatment fractions, respectively. Overall, the mean (range) deviation of -0.4 (-7.2 to 5.3) mm, -0.9 (-6.1 to 15.6) mm, and -1.7 (-7.0 to 6.1) mm was observed in Left-Right, Anterior-Posterior, and Superior-Inferior directions, respectively. The prostate CTV D99 would have been reduced by a maximum value of 1.3 Gy compared to the planned dose if position deviations were uncorrected, but with corrections, it was 0.3 Gy. Similarly, PTV D98 would have been reduced by a maximum value of 7.6 Gy uncorrected, with this difference reduced to 2.2 Gy with correction. The V60 to the rectum increased by a maximum of 1.0% uncorrected, which was reduced to 0.5%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Online target position monitoring for conventional fractionation prostate radiotherapy was successfully implemented on a standard Linear accelerator using an in-house developed position monitoring software, with an improvement in resultant dose to prostate target volume.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1082391","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T01:54:00Z","timestamp":1689386040000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Assessment of intrafraction motion and its dosimetric impact on prostate radiotherapy using an in-house developed position monitoring system"],"prefix":"10.3389","volume":"13","author":[{"given":"Sankar","family":"Arumugam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viet","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Chlap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Udovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sidhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70040-3","article-title":"Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial","volume":"15","author":"Dearnaley","year":"2014","journal-title":"Lancet Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ijrobp.2008.02.047","article-title":"Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy","volume":"72","author":"Palma","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2009.08.011","article-title":"Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer","volume":"93","author":"Wolff","year":"2009","journal-title":"Radiother Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.02.045","article-title":"Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers","volume":"60","author":"Aubry","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0360-3016(01)02654-2","article-title":"Daily prostate targeting using implanted radiopaque markers","volume":"52","author":"Litzenberg","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(01)00452-2","article-title":"Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers","volume":"61","author":"Wu","year":"2001","journal-title":"Radiother Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.radonc.2020.06.044","article-title":"Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5 T MR-linac","volume":"151","author":"de Muinck Keizer","year":"2020","journal-title":"Radiother Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.03.029","article-title":"Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers","volume":"69","author":"Kotte","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.12.033","article-title":"Influence of intrafraction motion on margins for prostate radiotherapy","volume":"65","author":"Litzenberg","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.02.001","article-title":"Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter-and intrafraction motion","volume":"78","author":"Tanyi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)02738-4","article-title":"Intrafraction prostate motion during IMRT for prostate cancer","volume":"53","author":"Huang","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.01.046","article-title":"The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans","volume":"84","author":"Langen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2006.03.005","article-title":"Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode","volume":"79","author":"Vetterli","year":"2006","journal-title":"Radiother Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.11.009","article-title":"Accuracy of a wireless localization system for radiotherapy","volume":"61","author":"Balter","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.01.050","article-title":"Target localization and real-time tracking using the calypso 4D localization system in patients with localized prostate cancer","volume":"65","author":"Willoughby","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.883725","article-title":"Intrafraction prostate motion management during dose-escalated linac-based stereotactic body radiation therapy","volume":"2022","author":"Panizza","year":"2022","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12885-017-3164-1","article-title":"Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: the TROG 15.01 SPARK trial","volume":"17","author":"Keall","year":"2017","journal-title":"BMC Cancer."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.radonc.2018.01.001","article-title":"The first clinical implementation of real-time image-guided adaptive radiotherapy using a standard linear accelerator","volume":"127","author":"Keall","year":"2018","journal-title":"Radiother Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1118\/1.2899998","article-title":"Prostate intrafraction motion evaluation using kV fluoroscopy during treatment delivery: a feasibility and accuracy study","volume":"35","author":"Adamson","year":"2008","journal-title":"Med Phys"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1118\/1.4940351","article-title":"An online x-ray based position validation system for prostate hypofractionated radiotherapy","volume":"43","author":"Arumugam","year":"2016","journal-title":"Med Phys"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13246-021-01007-0","article-title":"The first real-time intrafraction target position monitoring in pancreas SBRT on an elekta linear accelerator","volume":"2021","author":"Arumugam","year":"2021","journal-title":"Phys Eng Sci Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.10.017","article-title":"Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI)","volume":"62","author":"Ghilezan","year":"2005","journal-title":"Int J Radiat Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"235008","DOI":"10.1088\/1361-6560\/ab5539","article-title":"Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapy","volume":"64","author":"de Muinck Keizer","year":"2019","journal-title":"Phys Med Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2019.04.001","article-title":"Adaptive radiotherapy: the elekta unity MR-linac concept","volume":"18","author":"Winkel","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.616291","article-title":"MR-guided radiotherapy for prostate cancer","volume":"2020","author":"Tocco","year":"2020","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"91705","DOI":"10.1118\/1.4892605","article-title":"DMLC tracking and gating can improve dose coverage for prostate VMAT","volume":"41","author":"Colvill","year":"2014","journal-title":"Med Phys"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.12.017","article-title":"Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients","volume":"91","author":"Wortel","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2016.12.014","article-title":"Variable angle stereo imaging for rapid patient position correction in an in-house real-time position monitoring system","volume":"33","author":"Arumugam","year":"2017","journal-title":"Phys Medica."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(01)02805-X","article-title":"Inclusion of geometric uncertainties in treatment plan evaluation","volume":"52","author":"Van Herk","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1009916","article-title":"The delivered dose assessment in pancreas SBRT with the target position determined using an in-house position monitoring system","volume":"12","author":"Arumugam","year":"2022","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.07.2367","article-title":"Kilovoltage intrafraction monitoring for prostate intensity modulated arc therapy: first clinical results","volume":"84","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.10.026","article-title":"Multi-institutional clinical experience with the calypso system in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy","volume":"67","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.01.005","article-title":"Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability","volume":"62","author":"Kupelian","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.04.008","article-title":"In vivo validation of elekta\u2019s clarity autoscan for ultrasound-based intrafraction motion estimation of the prostate during radiation therapy","volume":"102","author":"Grimwood","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/1754-9485.13499","article-title":"Implementing online position monitoring for prostate radiotherapy using an in-house position monitoring system: user experience and impact on workforce","volume":"67","author":"Cardoso","year":"2023","journal-title":"J Med Imaging Radiat Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.11.054","article-title":"Observations on real-time prostate gland motion using electromagnetic tracking","volume":"71","author":"Langen","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.04.043","article-title":"Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion","volume":"81","author":"Shimizu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B40","doi-asserted-by":"publisher","first-page":"185003","DOI":"10.1088\/1361-6560\/ac8967","article-title":"Optimising multi-target multileaf collimator tracking using real-time dose for locally advanced prostate cancer patients","volume":"67","author":"Hewson","year":"2022","journal-title":"Phys Med Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.03.014","article-title":"Real-time image guided ablative prostate cancer radiation therapy: results from the TROG 15.01 SPARK trial","volume":"107","author":"Keall","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/cancers15041153","article-title":"Dosimetric impact of intrafraction prostate motion and interfraction anatomical changes in dose-escalated linac-based SBRT","volume":"15","author":"Faccenda","year":"2023","journal-title":"Cancers (Basel)."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.06.093","article-title":"Accurate accumulation of dose for improved understanding of radiation effects in normal tissue","volume":"76","author":"Jaffray","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-9-118","article-title":"Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system","volume":"9","author":"Shimizu","year":"2014","journal-title":"Radiat Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging\u2013guided vs computed tomography\u2013guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.radonc.2003.11.015","article-title":"Quantification of local rectal wall displacements by virtual rectum unfolding","volume":"70","author":"Hoogeman","year":"2004","journal-title":"Radiother Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00253-7","article-title":"Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer","volume":"33","author":"Lebesque","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijrobp.2007.05.046","article-title":"Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results","volume":"70","author":"Nijkamp","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.05.008","article-title":"Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy","volume":"79","author":"Peng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2010.11.016","article-title":"Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study","volume":"98","author":"L\u00fctgendorf-Caucig","year":"2011","journal-title":"Radiother Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1082391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T01:54:02Z","timestamp":1689386042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1082391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":50,"alternative-id":["10.3389\/fonc.2023.1082391"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1082391","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"article-number":"1082391"}}